Aesthetic Medicine Market Size to Hit USD 252.63 Bn by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Route of Administration Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Aesthetic Medicine Market

5.1. COVID-19 Landscape: Aesthetic Medicine Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Aesthetic Medicine Market, By Product Type

8.1. Aesthetic Medicine Market, by Product Type

8.1.1. Energy-Based Devices

8.1.1.1. Market Revenue and Forecast

8.1.2. Implants

8.1.2.1. Market Revenue and Forecast

8.1.3. Anti-Wrinkle Products

8.1.3.1. Market Revenue and Forecast

8.1.4. Dermal Fillers

8.1.4.1. Market Revenue and Forecast

8.1.5. Botulinum Toxin

8.1.5.1. Market Revenue and Forecast

8.1.6. Others

8.1.6.1. Market Revenue and Forecast

Chapter 9. Global Aesthetic Medicine Market, By Procedure Type

9.1. Aesthetic Medicine Market, by Procedure Type

9.1.1. Non-Invasive Procedure

9.1.1.1. Market Revenue and Forecast

9.1.2. Invasive Procedure

9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Aesthetic Medicine Market, By Application Type

10.1. Aesthetic Medicine Market, by Application Type

10.1.1. Surgical

10.1.1.1. Market Revenue and Forecast

10.1.2. Non-Surgical

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Aesthetic Medicine Market, By End-User Type

11.1. Aesthetic Medicine Market, by End-User Type

11.1.1. Medical Spas and Beauty Centres

11.1.1.1. Market Revenue and Forecast

11.1.2. Hospitals and Clinics

11.1.2.1. Market Revenue and Forecast

11.1.3. Ambulatory Surgical Centers

11.1.3.1. Market Revenue and Forecast

11.1.4. Others

11.1.4.1. Market Revenue and Forecast

Chapter 12. Global Aesthetic Medicine Market, By Gender

12.1. Aesthetic Medicine Market, by Gender

12.1.1. Males

12.1.1.1. Market Revenue and Forecast

12.1.2. Females

12.1.2.1. Market Revenue and Forecast

Chapter 13. Global Aesthetic Medicine Market, By Route of Administration

13.1. Aesthetic Medicine Market, by Procedure Type

13.1.1. Oral

13.1.1.1. Market Revenue and Forecast

13.1.2. Topical

13.1.2.1. Market Revenue and Forecast

Chapter 14. Global Aesthetic Medicine Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product

14.1.2. Market Revenue and Forecast, by Procedure

14.1.3. Market Revenue and Forecast, by Application

14.1.4. Market Revenue and Forecast, by End-User

14.1.5. Market Revenue and Forecast, by Gender

14.1.6. Market Revenue and Forecast, by Route of Administration

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Product

14.1.7.2. Market Revenue and Forecast, by Procedure

14.1.7.3. Market Revenue and Forecast, by Application

14.1.7.4. Market Revenue and Forecast, by End-User

14.1.8. Market Revenue and Forecast, by Gender

14.1.8.1. Market Revenue and Forecast, by Route of Administration

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product

14.1.9.2. Market Revenue and Forecast, by Procedure

14.1.9.3. Market Revenue and Forecast, by Application

14.1.9.4. Market Revenue and Forecast, by End-User

14.1.10. Market Revenue and Forecast, by Gender

14.1.11. Market Revenue and Forecast, by Route of Administration

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product

14.2.2. Market Revenue and Forecast, by Procedure

14.2.3. Market Revenue and Forecast, by Application

14.2.4. Market Revenue and Forecast, by End-User

14.2.5. Market Revenue and Forecast, by Gender

14.2.6. Market Revenue and Forecast, by Route of Administration

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product

14.2.8.2. Market Revenue and Forecast, by Procedure

14.2.8.3. Market Revenue and Forecast, by Application

14.2.9. Market Revenue and Forecast, by End-User

14.2.10. Market Revenue and Forecast, by Gender

14.2.10.1. Market Revenue and Forecast, by Route of Administration

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Product

14.2.11.2. Market Revenue and Forecast, by Procedure

14.2.11.3. Market Revenue and Forecast, by Application

14.2.12. Market Revenue and Forecast, by End-User

14.2.13. Market Revenue and Forecast, by Gender

14.2.14. Market Revenue and Forecast, by Route of Administration

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Product

14.2.15.2. Market Revenue and Forecast, by Procedure

14.2.15.3. Market Revenue and Forecast, by Application

14.2.15.4. Market Revenue and Forecast, by End-User

14.2.16. Market Revenue and Forecast, by Gender

14.2.16.1. Market Revenue and Forecast, by Route of Administration

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Product

14.2.17.2. Market Revenue and Forecast, by Procedure

14.2.17.3. Market Revenue and Forecast, by Application

14.2.17.4. Market Revenue and Forecast, by End-User

14.2.18. Market Revenue and Forecast, by Gender

14.2.18.1. Market Revenue and Forecast, by Route of Administration

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product

14.3.2. Market Revenue and Forecast, by Procedure

14.3.3. Market Revenue and Forecast, by Application

14.3.4. Market Revenue and Forecast, by End-User

14.3.5. Market Revenue and Forecast, by Gender

14.3.6. Market Revenue and Forecast, by Route of Administration

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Product

14.3.7.2. Market Revenue and Forecast, by Procedure

14.3.7.3. Market Revenue and Forecast, by Application

14.3.7.4. Market Revenue and Forecast, by End-User

14.3.8. Market Revenue and Forecast, by Gender

14.3.9. Market Revenue and Forecast, by Route of Administration

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Product

14.3.10.2. Market Revenue and Forecast, by Procedure

14.3.10.3. Market Revenue and Forecast, by Application

14.3.10.4. Market Revenue and Forecast, by End-User

14.3.11. Market Revenue and Forecast, by Gender

14.3.11.1. Market Revenue and Forecast, by Route of Administration

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Product

14.3.12.2. Market Revenue and Forecast, by Procedure

14.3.12.3. Market Revenue and Forecast, by Application

14.3.12.4. Market Revenue and Forecast, by End-User

14.3.12.5. Market Revenue and Forecast, by Gender

14.3.12.6. Market Revenue and Forecast, by Route of Administration

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Product

14.3.13.2. Market Revenue and Forecast, by Procedure

14.3.13.3. Market Revenue and Forecast, by Application

14.3.13.4. Market Revenue and Forecast, by End-User

14.3.13.5. Market Revenue and Forecast, by Gender

14.3.13.6. Market Revenue and Forecast, by Route of Administration

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product

14.4.2. Market Revenue and Forecast, by Procedure

14.4.3. Market Revenue and Forecast, by Application

14.4.4. Market Revenue and Forecast, by End-User

14.4.5. Market Revenue and Forecast, by Gender

14.4.6. Market Revenue and Forecast, by Route of Administration

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Product

14.4.7.2. Market Revenue and Forecast, by Procedure

14.4.7.3. Market Revenue and Forecast, by Application

14.4.7.4. Market Revenue and Forecast, by End-User

14.4.8. Market Revenue and Forecast, by Gender

14.4.9. Market Revenue and Forecast, by Route of Administration

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Product

14.4.10.2. Market Revenue and Forecast, by Procedure

14.4.10.3. Market Revenue and Forecast, by Application

14.4.10.4. Market Revenue and Forecast, by End-User

14.4.11. Market Revenue and Forecast, by Gender

14.4.12. Market Revenue and Forecast, by Route of Administration

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Product

14.4.13.2. Market Revenue and Forecast, by Procedure

14.4.13.3. Market Revenue and Forecast, by Application

14.4.13.4. Market Revenue and Forecast, by End-User

14.4.13.5. Market Revenue and Forecast, by Gender

14.4.13.6. Market Revenue and Forecast, by Route of Administration

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Product

14.4.14.2. Market Revenue and Forecast, by Procedure

14.4.14.3. Market Revenue and Forecast, by Application

14.4.14.4. Market Revenue and Forecast, by End-User

14.4.14.5. Market Revenue and Forecast, by Gender

14.4.14.6. Market Revenue and Forecast, by Route of Administration

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product

14.5.2. Market Revenue and Forecast, by Procedure

14.5.3. Market Revenue and Forecast, by Application

14.5.4. Market Revenue and Forecast, by End-User

14.5.5. Market Revenue and Forecast, by Gender

14.5.6. Market Revenue and Forecast, by Route of Administration

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Product

14.5.7.2. Market Revenue and Forecast, by Procedure

14.5.7.3. Market Revenue and Forecast, by Application

14.5.7.4. Market Revenue and Forecast, by End-User

14.5.8. Market Revenue and Forecast, by Gender

14.5.8.1. Market Revenue and Forecast, by Route of Administration

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product

14.5.9.2. Market Revenue and Forecast, by Procedure

14.5.9.3. Market Revenue and Forecast, by Application

14.5.9.4. Market Revenue and Forecast, by End-User

14.5.9.5. Market Revenue and Forecast, by Gender

14.5.9.6. Market Revenue and Forecast, by Route of Administration

Chapter 15. Company Profiles

15.1. AbbVie Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Galderma

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Alma Lasers

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Cynosure

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Johnson & Johnson Private Limited

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Lumenis Be Ltd.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Solta Medical

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Candela Medical

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Hologic, Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Dentsply Sirona

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The global aesthetic medicine market size was valued at USD 100.47 billion in 2025 and is expected to reach USD 252.63 billion by 2035.

Answer : The global aesthetic medicine market is anticipated to grow at a CAGR of 9.66% during the forecast period.

Answer : The major players operating in the aesthetic medicine market are AbbVie Inc., Galderma, Alma Lasers, Cynosure, Johnson & Johnson Private Limited, Lumenis Be Ltd., Solta Medical, Candela Medical, Hologic, Inc., and Dentsply Sirona.

Answer : Major growth drivers include rising demand for minimally invasive procedures, advancements in AI-enabled aesthetic technologies, increasing aging populations, social media influence, medical tourism, and growing awareness of cosmetic treatments.

Answer : North America accounted for the largest market share in 2025 due to advanced healthcare infrastructure, high consumer spending, and strong adoption of cosmetic procedures.